Pitt Street Research Valuation Report – “Following the gut”
Pitt Street Research has released its follow-up research and valuation report on Anatara Lifesciences (ANR). The report valued Anatara at $1.34 base case and $3.61 optimistic case using a probability-weighted DCF valuation approach.
Please click on the PDF to view the report.